Bicocca Open Archive

Logo unimib boa
OKOLICSANYI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.339
EU - Europa 2.054
AS - Asia 926
SA - Sud America 96
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 7.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.267
IT - Italia 380
DE - Germania 363
SG - Singapore 358
CN - Cina 337
RU - Federazione Russa 274
SE - Svezia 261
IE - Irlanda 207
UA - Ucraina 168
GB - Regno Unito 120
HK - Hong Kong 78
BR - Brasile 77
CA - Canada 71
AT - Austria 67
DK - Danimarca 66
IN - India 53
FI - Finlandia 47
VN - Vietnam 34
FR - Francia 29
TR - Turchia 21
BE - Belgio 20
NL - Olanda 18
KR - Corea 14
ES - Italia 8
IR - Iran 6
EC - Ecuador 5
CZ - Repubblica Ceca 4
TW - Taiwan 4
AR - Argentina 3
AU - Australia 3
BD - Bangladesh 3
CH - Svizzera 3
CL - Cile 3
EU - Europa 3
IQ - Iraq 3
JP - Giappone 3
NO - Norvegia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
ID - Indonesia 2
JO - Giordania 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
MX - Messico 1
PH - Filippine 1
RO - Romania 1
UY - Uruguay 1
Totale 7.435
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Woodbridge 462
Fairfield 339
Houston 292
Chandler 271
Ashburn 247
Wilmington 230
Singapore 226
Frankfurt am Main 206
Dublin 200
Dearborn 166
Jacksonville 157
Cambridge 133
Seattle 132
New York 112
Milan 111
Princeton 81
Hong Kong 78
Santa Clara 70
Vienna 65
Nanjing 64
Shanghai 49
Altamura 39
Lawrence 38
Lachine 26
Council Bluffs 22
Tianjin 22
Nanchang 21
Guangzhou 20
Shenyang 20
Dong Ket 18
San Diego 18
Beijing 17
Fremont 16
Helsinki 16
Brussels 15
Ottawa 15
Jinan 14
Boston 13
Andover 12
Boardman 12
Kunming 12
Moscow 12
Edmonton 11
Lissone 11
Los Angeles 11
Mountain View 10
Nürnberg 10
Toronto 10
Changsha 8
Falls Church 8
Hangzhou 8
Hebei 8
Jiaxing 8
Ningbo 7
Valencia 7
Zhengzhou 7
Busto Arsizio 6
Kiev 6
London 6
Manchester 6
Pune 6
Taizhou 6
Washington 6
Valmadrera 5
Bergamo 4
Chicago 4
Delhi 4
Hounslow 4
Indianapolis 4
Montréal 4
Nottingham 4
Nuremberg 4
Nutley 4
Padova 4
Rome 4
Sacramento 4
Segrate 4
Seoul 4
Taipei 4
Verona 4
Baghdad 3
Dallas 3
Dhaka 3
Hefei 3
Lanzhou 3
Legnano 3
Munich 3
Newtyle 3
Phoenix 3
Quito 3
Rio Grande 3
Saint-Maurice-en-Gourgois 3
São Paulo 3
Tappahannock 3
Wenzhou 3
Aachen 2
Assèmini 2
Auburn Hills 2
Auckland 2
Totale 5.239
Salva come PNG Salva come JPEG
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 388
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 362
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 316
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 265
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 258
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 227
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 214
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 212
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 210
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 207
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 206
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 203
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 203
Health Related Quality of Life in the Major Liver Conditions 195
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 194
Health related quality of life in chronic liver diseases 194
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 193
The impact of liver disease on the health-related quality of life 191
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 187
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 185
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 185
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 185
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 178
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 178
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 177
Liver-allocation policies for patients affected by HCC in Europe 172
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 171
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 171
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 167
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 165
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 164
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 161
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 159
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 157
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 152
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 152
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 147
Difference in health related quality of life of chronic liver diseases and general population 123
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 120
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 118
Totale 7.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020212 0 0 0 0 0 0 0 0 0 103 90 19
2020/2021929 46 55 109 111 93 73 59 85 77 83 59 79
2021/2022551 51 59 72 57 16 41 19 41 26 37 38 94
2022/20231.054 106 369 88 90 56 139 21 73 68 3 31 10
2023/2024647 21 27 15 49 58 213 127 24 40 6 5 62
2024/20251.119 86 160 115 47 123 59 99 49 196 185 0 0
Totale 7.812